Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

The Vermont pandemic death total stands at 1,278 as of March 6, 2025, an increase of 2 from the previous week (the most ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that members of management ...

During one of the most active flu seasons in recent memory, infectious disease experts at Cancer Center say many of the ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Traditionally, the microbiologic diagnosis of RSV has been based on moderate to complex techniques performed in a laboratory (cell culture, nucleic acid amplification and immunofluorescence assays ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

Cold germs from someone’s nose or cough can live on surfaces for hours to days, depending on many factors. Learn which ...

CompanyOverview\|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.

Getting vaccinated continues to be the most effective way to prevent infection, local health experts say, as the number of confirmed measles cases grows nationwide.